Company intelligence / Profile preview

Wuhan Zhong Yuan Rui De Biological Products Co., Ltd.

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Manufacturer of commercial plasma-derived products including human albumin and human immunoglobulin (pH4) for intravenous injection, with historical pipeline of coagulation factors.

Modalities: BiologicRecombinant protein
Industry: Biotech

Drug pipeline

2 assets

Intravenous Human Immunoglobulin (pH4) (Wuhan Zhong Yuan Rui De)

1 more asset in the full pipeline.

Partnerships

CSL (former majority owner)Humanwell Healthcare Group (former owner)

Beyond the preview

Go deeper on Wuhan Zhong Yuan Rui De Biological Products Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Zhong Yuan Rui De Biological Products Co., Ltd..